Oncolytic adenovirus-mediated delivery of anti-CLDN18.2 IgG3 for the treatment of solid tumors 9 de October de 2026 by Pei, L., Zhang, W., Zhu, H., Xu, X., Guo, Q., Meng, Y., Pang, W., Zhang, Y., Zeng, W., Ma, M., Liu, Y., Luo, G.
Pei, L., Zhang, W., Zhu, H., Xu, X., Guo, Q., Meng, Y., Pang, W., Zhang, Y., Zeng, W., Ma, M., Liu, Y., Luo, G. 